ARTICLE | Company News
Axentis, BioDevelops deal
June 30, 2008 7:00 AM UTC
Axentis acquired BioDevelops Pharma for an undisclosed amount. The acquisition gave Axentis exclusive rights to IP covering the use of molecules for the enzymatic removal of ubiquitin markers from inc...